Pooriwat Lertsurawat
Songkhla, Changwat Songkhla, 90110, Thailand
NCT Number: NCT06232018
The goal of this randomized controlled study is to investigate the Efficacy of Using skin adhesive (Dermabond) and skin adhesive with polyester mesh (Dermabond Prineo )for Wound Closure in Total Knee Arthroplasty, The main question it aim to answer
1 Are skin adhesive alone and with Polyester mesh in Total knee arthroplasty different in Patient satisfaction evaluated by POSAS score
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Not applicable
Songkhla, Changwat Songkhla, 90110, Thailand
Nowadays, there are many methods of wound closure in Total Knee arthroplasty, such as nylon, skin staple, and sterile strip, which differ in advantages and disadvantages of each technique. However, these methods have the same disadvantages: wound discharge, which may lead to infection, wound separation, and the need for wound dressing. It is also a burden for patients and caregivers. In travelling to change the wound in a hospital, There are many costs in terms of wound dressing equipment, travel costs and time off from work for caregivers to take patients to get wound dressing.
Skin adhesive is an innovation for wound closure in total knee arthroplasty. It reduces the problem of wound separation, with no need for wound dressing.
Skin adhesive mesh has been studied in many studies, showing that it can be used well. Strong It is no different from traditional wound closure; the scar is more beautiful. Patients are more satisfied. But the disadvantage is the high price.
Skin adhesive without polyester mesh has the advantage of being cheaper three times than polyester mesh but less intense than with mesh. This makes it unpopular.
No studies have been found comparing wound dressings with mesh and no mesh After knee replacement surgery.
Therefore, this study is to compare skin adhesive and skin adhesive plus polyester mesh in closure wound total knee arthroplasty.
Are there differences in patient satisfaction Are wound complications such as wound oozing, wound separation, superficial wound skin infection, and contact dermatitis different?
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 weeks
Evaluated Patient observer scar assessment score (POSAS)
Time frame: 3 months
Evaluated Patient observer scar assessment score (POSAS)
Time frame: 6 weeks
Evaluated vancouver scar scale
Vancouver Scar Scale (VSS) is used for validated scar assessment tools. Consist of the four following parts: vascularity(0-3) , height(0-3), pliability(0-5), and pigmentation(0-2). Each characteristic is given a score, which are added together to give an overall score between 0 and 13. The lowest score is 0 and corresponds to the normal skin. The highest score is 13 and corresponds to the worst skin.
Time frame: 2 weeks
Wound leakage was evaluated by measuring the total blood-stained area on the waterproof dressing.
The dressing was placed on a standardized 1 mm² grid, and the stained area was calculated in square millimeters (mm²).
Time frame: 3 months
Evaluated vancouver scar scale
Vancouver Scar Scale (VSS) is used for validated scar assessment tools. Consist of the four following parts: vascularity(0-3) , height(0-3), pliability(0-5), and pigmentation(0-2). Each characteristic is given a score, which are added together to give an overall score between 0 and 13. The lowest score is 0 and corresponds to the normal skin. The highest score is 13 and corresponds to the worst skin.
Pooriwat Lertsurawat
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06717529
Arthritis, Joint Diseases
Mostar, Bosnia and Herzegovina
View Trial DetailsNCT02285725
Arthritis, Degeneration; Articular Cartilage, Knee
View Trial DetailsNCT01934218
Arthritis, Joint Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT02544802
Arthritis, Joint Diseases
Taipei, Taiwan
View Trial Details